Kingworld Medicines Group (HKSE:01110) 3-Year EBITDA Growth Rate : -0.10% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group 3-Year EBITDA Growth Rate?

Kingworld Medicines Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.07.

During the past 12 months, Kingworld Medicines Group's average EBITDA Per Share Growth Rate was 6.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -0.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kingworld Medicines Group was 30.90% per year. The lowest was -9.90% per year. And the median was 0.20% per year.

Competitive Comparison of Kingworld Medicines Group's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kingworld Medicines Group's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's 3-Year EBITDA Growth Rate falls into.

Kingworld Medicines Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kingworld Medicines Group (HKSE:01110) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kingworld Medicines Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines